Lv24
158 积分 2023-08-23 加入
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
5小时前
已完结
Adopting GPR75 in treating obesity: unraveling the knowns and unknowns of this orphan GPCR
3天前
已完结
Orphan G-protein coupled receptor 75 (GPR75), a unique and controversial potential therapeutic target
3天前
已完结
Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors
8天前
已完结
Site-Specific Conjugation to Cys-Engineered THIOMAB™ Antibodies
16天前
已完结
Engineering Antibody Reactivity for Efficient Derivatization to Generate NaV1.7 Inhibitory GpTx-1 Peptide–Antibody Conjugates
17天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
21天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
21天前
已完结
Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins
1个月前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
1个月前
已完结
皖公网安备34019202002308
